# Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes

> **NCT02950987** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 150 (estimated)

## Conditions studied

- Li-Fraumeni Syndrome

## Interventions

- **DEVICE:** Whole Body MRI

## Key facts

- **NCT ID:** NCT02950987
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-03
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02950987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02950987, "Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02950987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*